| CD1-dependent dendritic cell instruction MS Vincent, DS Leslie, JE Gumperz, X Xiong, EP Grant, MB Brenner Nature immunology 3 (12), 1163-1168, 2002 | 291 | 2002 |
| A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee SB Cohen, S Proudman, AJ Kivitz, FX Burch, JP Donohue, D Burstein, ... Arthritis research & therapy 13, 1-12, 2011 | 274 | 2011 |
| CD1-mediated γ/δ T cell maturation of dendritic cells DS Leslie, MS Vincent, FM Spada, H Das, M Sugita, CT Morita, ... The Journal of experimental medicine 196 (12), 1575-1584, 2002 | 264 | 2002 |
| Efficacy and safety of oral Janus kinase 1 inhibitor abrocitinib for patients with atopic dermatitis: a phase 2 randomized clinical trial MJ Gooderham, SB Forman, R Bissonnette, JS Beebe, W Zhang, ... JAMA dermatology 155 (12), 1371-1379, 2019 | 216 | 2019 |
| Understanding the function of CD1-restricted T cells MS Vincent, JE Gumperz, MB Brenner Nature immunology 4 (6), 517-523, 2003 | 159 | 2003 |
| Apoptosis of Fashigh CD4+ Synovial T Cells by Borrelia-reactive Fas-ligandhigh γδ T Cells in Lyme Arthritis MS Vincent, K Roessner, D Lynch, D Wilson, SM Cooper, J Tschopp, ... The Journal of experimental medicine 184 (6), 2109-2118, 1996 | 142 | 1996 |
| Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial DJ Wallace, V Strand, JT Merrill, S Popa, AJ Spindler, A Eimon, M Petri, ... Annals of the rheumatic diseases 76 (3), 534-542, 2017 | 130 | 2017 |
| A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24 … B King, E Guttman-Yassky, E Peeva, A Banerjee, R Sinclair, AB Pavel, ... Journal of the American Academy of Dermatology 85 (2), 379-387, 2021 | 113 | 2021 |
| Serum lipids regulate dendritic cell CD1 expression and function DS Leslie, CC Dascher, K Cembrola, MA Townes, DL Hava, ... Immunology 125 (3), 289-301, 2008 | 102 | 2008 |
| The safety, tolerability, pharmacokinetics, and pharmacodynamics of a TYK2/JAK1 inhibitor (PF‐06700841) in healthy subjects and patients with plaque psoriasis C Banfield, M Scaramozza, W Zhang, E Kieras, KM Page, A Fensome, ... The Journal of Clinical Pharmacology 58 (4), 434-447, 2018 | 90 | 2018 |
| Lyme arthritis synovial γδ T cells respond to Borrelia burgdorferi lipoproteins and lipidated hexapeptides MS Vincent, K Roessner, T Sellati, CD Huston, LH Sigal, SM Behar, ... The Journal of Immunology 161 (10), 5762-5771, 1998 | 72 | 1998 |
| Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab B Gorovits, DJ Baltrukonis, I Bhattacharya, MA Birchler, D Finco, ... Clinical & Experimental Immunology 192 (3), 348-365, 2018 | 70 | 2018 |
| Efficacy and safety of PF‐06651600 (Ritlecitinib), a novel Jak3/TEC inhibitor, in patients with Moderate‐To‐Severe rheumatoid arthritis and an inadequate response to methotrexate MF Robinson, N Damjanov, B Stamenkovic, G Radunovic, A Kivitz, L Cox, ... Arthritis & Rheumatology 72 (10), 1621-1631, 2020 | 69 | 2020 |
| TYK2/JAK1 inhibitor PF-06700841 in patients with plaque psoriasis: phase IIa, randomized, double-blind, placebo-controlled trial SB Forman, DM Pariser, Y Poulin, MS Vincent, SA Gilbert, EM Kieras, ... Journal of Investigative Dermatology 140 (12), 2359-2370. e5, 2020 | 61 | 2020 |
| Population PK and IgE pharmacodynamic analysis of a fully human monoclonal antibody against IL4 receptor T Kakkar, C Sung, L Gibiansky, T Vu, A Narayanan, SL Lin, M Vincent, ... Pharmaceutical research 28, 2530-2542, 2011 | 59 | 2011 |
| CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens MS Vincent, X Xiong, EP Grant, W Peng, MB Brenner The Journal of Immunology 175 (10), 6344-6351, 2005 | 57 | 2005 |
| Molecular recognition of human CD1b antigen complexes: evidence for a common pattern of interaction with αβ TCRs A Melián, GFM Watts, A Shamshiev, G De Libero, A Clatworthy, M Vincent, ... The Journal of Immunology 165 (8), 4494-4504, 2000 | 57 | 2000 |
| QuickMIRSeq: a pipeline for quick and accurate quantification of both known miRNAs and isomiRs by jointly processing multiple samples from microRNA sequencing S Zhao, W Gordon, S Du, C Zhang, W He, L Xi, S Mathur, M Agostino, ... BMC bioinformatics 18, 1-14, 2017 | 50 | 2017 |
| QuickRNASeq lifts large-scale RNA-seq data analyses to the next level of automation and interactive visualization S Zhao, L Xi, J Quan, H Xi, Y Zhang, D von Schack, M Vincent, B Zhang BMC genomics 17, 1-15, 2016 | 46 | 2016 |
| Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: a randomized phase 2b clinical trial K Ezzedine, E Peeva, Y Yamaguchi, LA Cox, A Banerjee, G Han, ... Journal of the American Academy of Dermatology 88 (2), 395-403, 2023 | 42 | 2023 |
